PBAC fast-tracks molnupiravir for streamlined authority listing
The federal Department of Health has offered advice on splitting the capsules to make an oral solution
GPs are a step closer to prescribing COVID-19 antivirals on the PBS after a fast-tracked recommendation on Friday for the listing of molnupiravir.
Molnupiravir (Lagevrio from Merck Sharp & Dohme) and nirmatrelvir–ritonavir (Paxlovid from Pfizer) have been available through the National Medical Stockpile for about two weeks, with officials warning PBS listings might be “months away”.
